Tumor blood flow measurements using coincidence counting on patients treated with neutrons.

Abstract

PURPOSE:

The purpose of this work was to measure blood flow in tumors using a coincidence counting technique on patients undergoing treatment with neutrons.

METHODS AND MATERIALS:

The half-time, Tw, for the washout of 15O from neutron-activated tumors was measured with two 10 cm NaI(Tl) crystals coupled to a PC-based coincidence counting system. Blood flow measurements were made in 33 patients, 19 of whom had cancers of the head and neck region, 6 had breast cancer, 5 had sarcomas, and 3 patients had mesotheliomas.

RESULTS:

Blood flow as indicated by Tw of mobile 15O formed by neutron activation could be readily determined in tumors of patients undergoing neutron radiotherapy. The general reduction in the value for Tw was noted towards the end of treatment and did not seem to be dependent on the initial tumor volume. There was a tendency for larger lesions to be associated with longer half-times of 15O washout.

CONCLUSION:

It appears possible to obtain a reasonable estimate of tumor blood flow using a simple coincidence counting technique. In view of the large variation in blood flow between tumors, it did not appear to be possible to identify potentially hypoxic tumors that would respond to neutron therapy.

• Authors: E R Hering, G H Blekkenhorst, D T Jones
• Journal: International journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 32 Issue 1 Pg. 129-35 (Apr 30 1995) ISSN: 0360-3016 [Print] United States
• PMID: 7721609 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Oxygen Radioisotopes

Topics

• Breast Neoplasms (blood, blood supply, pathology, radiotherapy)
• Half-Life
• Head and Neck Neoplasms (blood, blood supply, pathology, radiotherapy)
• Humans
• Mesothelioma (blood, blood supply, pathology, radiotherapy)
• Neoplasms (blood, blood supply, pathology, radiotherapy)
• Neutrons (therapeutic use)
• Oxygen Radioisotopes (metabolism)
• Regional Blood Flow
• Sarcoma (blood, blood supply, pathology, radiotherapy)
• Time Factors